Hepatitis E in Southeast Asia
DOI:
https://doi.org/10.33192/Smj.2020.35Keywords:
Epidemiology, genotype, seroepidemiologic studies, vaccination; swineAbstract
Hepatitis E is a major cause of acute viral hepatitis in the world. The causative agent of hepatitis E is hepatitis E virus (HEV). In Southeast Asia, the seroprevalence of HEV and the most prevalent genotype of HEV are largely unclear and the available data is either limited or outdated. After a systematic review of literature, we found the seroprevalence of HEV and the most prevalent genotype of HEV appear to vary greatly by countries. The seroprevalence is likely between 17% to 42% and the prevalent genotypes across Southeast Asia are likely 1, 3, and 4, but not 2 as no cases of genotype 2 have been reported in this region. As HEV remains widespread in Southeast Asia and the clinical implications of HEV can be severe, surveillance programs for HEV should be implemented.
References
2. Kamar N, Bendall R, Legrand-Abravanel F, Xia N-S, Ijaz S, Izopet J, et al. Hepatitis E. Lancet 2012;379:2477-88.
3. Okamoto H. Genetic variability and evolution of hepatitis E virus. Virus Res 2007;127:216-28.
4. Tam AW, Smith MM, Guerra ME, Huang C-C, Bradley DW, Fry KE, et al. Hepatitis E virus (HEV): Molecular cloning and sequencing of the full-length viral genome. Virology 1991;185:120-31.
5. Provost PJ, Wolanski BS, Miller WJ, Ittensohn OL, McAleer WJ, Hilleman MR. Physical, Chemical and Morphologic Dimensions of Human Hepatitis A Virus Strain CR326. Exp Biol Med 1975;148:532-9.
6. Geng Y, Wang Y. Transmission of Hepatitis E Virus. In: Advances in Experimental Medicine and Biology. Springer New York LLC; 2016. p. 89-112.
7. Teshale EH, Hu DJ. Hepatitis E: Epidemiology and prevention. World J Hepatol 2011;3:285-91.
8. Lee GH, Tan BH, Chi-Yuan Teo E, Lim SG, Dan YY, Wee A, et al. Chronic Infection With Camelid Hepatitis E Virus in a Liver Transplant Recipient Who Regularly Consumes Camel Meat and Milk. Gastroenterology 2016;150:355-7.e3.
9. Lu L, Li C, Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol 2006;16:5-36.
10. Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK. Maternal and Fetal Outcomes in Pregnant Women with Acute Hepatitis E Virus Infection. Ann Intern Med 2007;147:28.
11. Kumar A, Saraswat VA. Hepatitis E and Acute-on-Chronic Liver Failure. J Clin Exp Hepatol 2013;3:225-30.
12. Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, Nelson KE. Epidemiology of Hepatitis E Virus in the United States: Results from the Third National Health and Nutrition Examination Survey, 1988-1994. J Infect Dis 2009;200:48-56.
13. Velázquez O, Stetler HC, Avila C, Ornelas G, Alvarez C, Hadler SC, et al. Epidemic Transmission of Enterically Transmitted Non-A, Non-B Hepatitis in Mexico, 1986-1987. JAMA J Am Med Assoc 1990;263:3281-5.
14. Centers for Disease Control (CDC). Enterically transmitted non-A, non-B hepatitis--Mexico. MMWR Morb Mortal Wkly Rep 1987;36:597-602.
15. Yugo DM, Meng XJ. Hepatitis E virus: Foodborne, waterborne and zoonotic transmission. Vol. 10, International Journal of Environmental Research and Public Health. 2013. p. 4507-33.
16. Tei S, Kitajima N, Takahashi K, Mishiro S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet 2003;362:371-3.
17. Purcell RH, Emerson SU. Hepatitis E: An emerging awareness of an old disease. J Hepatol 2008;48:494-503.
18. Aggarwal R, Naik S. Epidemiology of hepatitis E: Current status. J Gastroenterol Hepatol 2009;24:1484-93.
19. Rianthavorn P, Thongmee C, Limpaphayom N, Komolmit P, Theamboonlers A, Poovorawan Y. The entire genome sequence of hepatitis e virus genotype 3 isolated from a patient with neuralgic amyotrophy. Scand J Infect Dis 2010;42:395-400.
20. Intharasongkroh D, Thongmee T, Sa-Nguanmoo P, Klinfueng S, Duang-In A, Wasitthankasem R, et al. Hepatitis E virus infection in Thai blood donors. Transfusion 2019;59:1035-43.
21. Siripanyaphinyo U, Boon-Long J, Louisirirotchanakul S, Takeda N, Chanmanee T, Srimee B, et al. Occurrence of hepatitis E virus infection in acute hepatitis in Thailand. J Med Virol 2014;86:1730-5.
22. Yamada H, Takahashi K, Lim O, Svay S, Chuon C, Hok S, et al. Hepatitis E virus in Cambodia: Prevalence among the general population and complete genome sequence of genotype 4. PLoS One 2015;10(8).
23. Li TC, Yang T, Shiota T, Yoshizaki S, Yoshida H, Saito M, et al. Molecular detection of hepatitis e virus in rivers in the Philippines. Am J Trop Med Hyg 2014;90:764-6.
24. Suwannakarn K, Tongmee C, Theamboonlers A, Komolmit P, Poovorawan Y. Swine as the possible source of hepatitis E virus transmission to humans in Thailand. Arch Virol 2010;155:1697-9.
25. Cooper K, Huang FF, Batista L, Rayo CD, Bezanilla JC, Toth TE, et al. Identification of genotype 3 hepatitis E virus (HEV) in serum and fecal samples from pigs in Thailand and Mexico, where genotype 1 and 2 HEV strains are prevalent in the respective human populations. J Clin Microbiol 2005;43:1684-8.
26. Wiratsudakul A, Sariya L, Prompiram P, Tantawet S, Suraruangchai D, Sedwisai P, et al. Detection and Phylogenetic Characterization of Hepatitis E Virus Genotype 3 in a Captive Wild Boar in Thailand. J Zoo Wildl Med 2012;43:640-4.
27. Siripanyaphinyo U, Laohasinnarong D, Siripanee J, Kaeoket K, Kameoka M, Ikuta K, et al. Full-length sequence of genotype 3 hepatitis e virus derived from a pig in Thailand. J Med Virol 2009;81:657-64.
28. Keawcharoen J, Thongmee T, Panyathong R, Joiphaeng P, Tuanthap S, Oraveerakul K, et al. Hepatitis e virus genotype 3f sequences from pigs in Thailand, 2011-2012. Virus Genes 2013;46:369-70.
29. Gonwong S, Chuenchitra T, Khantapura P, Islam D, Sirisopana N, Mason CJ. Pork consumption and seroprevalence of hepatitis E virus, Thailand, 2007-2008. Emerg Infect Dis 2014;20:1531-4.
30. Sa-Nguanmoo P, Posuwan N, Vichaiwattana P, Wutthiratkowit N, Owatanapanich S, Wasitthankasem R, et al. Swine is a possible source of hepatitis E virus infection by comparative study of hepatitis A and E seroprevalence in Thailand. PLoS One 2015 ;10(4).
31. Jupattanasin S, Chainuvati S, Chotiyaputta W, Chanmanee T, Supapueng O, Charoonruangrit U, et al. A Nationwide Survey of the Seroprevalence of Hepatitis E Virus Infections Among Blood Donors in Thailand. Viral Immunol 2019;32:302-7.
32. Enouf V, Dos Reis G, Guthmann JP, Guerin PJ, Caron M, Marechal V, et al. Validation of single real-time TaqMan® PCR assay for the detection and quantitation of four major genotypes of hepatitis E virus in clinical specimens. J Med Virol 2006;78:1076-82.
33. Caron M, Enouf V, Than SC, Dellamonica L, Buisson Y, Nicand E. Identification of genotype 1 hepatitis E virus in samples from swine in Cambodia. J Clin Microbiol 2006;44:3440-2.
34. Kitajima M, Matsubara K, Sour S, Haramoto E, Katayama H, Ohgaki S. First detection of genotype 3 hepatitis E virus RNA in river water in Cambodia. Trans R Soc Trop Med Hyg 2009;103:955-7.
35. Blacksell SD, Myint KSA, Khounsy S, Phruaravanh M, Mammen MP, Day NPJ, et al. Prevalence of hepatitis E virus antibodies in pigs: implications for human infections in village-based subsistence pig farming in the Lao PDR. Trans R Soc Trop Med Hyg 2007;101:305-7.
36. Conlan J V., Jarman RG, Vongxay K, Chinnawirotpisan P, Melendrez MC, Fenwick S, et al. Hepatitis E virus is prevalent in the pig population of Lao People’s Democratic Republic and evidence exists for homogeneity with Chinese Genotype 4 human isolates. Infect Genet Evol 2011;11:1306-11.
37. Conlan J V., Vongxay K, Jarman RG, Gibbons R V., Lunt RA, Fenwick S, et al. Serologic study of pig-associated viral zoonoses in Laos. Am J Trop Med Hyg 2012;86:1077-84.
38. Bounlu K, Insisiengmay S, Vanthanouvong K, Saykham, Widjaja S, Iinuma K, et al. Acute Jaundice in Vientiane, Lao People’s Democratic Republic. Clin Infect Dis 1998;27:717-21.
39. Seow HF, Mahomed NMB, Mak JW, Riddell MA, Li F, Anderson DA. Seroprevalence of antibodies to hepatitis E virus in the normal blood donor population and two aboriginal communities in Malaysia. J Med Virol 1999;59:164-8.
40. Ng KP, He J, Saw TL, Lyles CM. A seroprevalence study of viral hepatitis E infection in human immunodeficiency virus type 1 infected subjects in Malaysia. Med J Malaysia. 2000;55:58-64.
41. Aye TT, Uchida T, Ma X, IIda F, Shikata T, Ichikawa M, et al. Sequence and gene structure of the hepatitis E virus isolated from Myanmar. Virus Genes 1993;7:95-109.
42. Nakai K, Khin Maung Win, San San Oo, Arakawa Y, Abe K. Molecular characteristic-based epidemiology of hepatitis B, C, and E viruses and GB virus C/hepatitis G virus in Myanmar. J Clin Microbiol 2001;39:1536-9.
43. Koizumi Y, Isoda N, Sato Y, Iwaki T, Ono K, Ido K, et al. Infection of a Japanese patient by genotype 4 hepatitis E virus while traveling in Vietnam. J Clin Microbiol 2004;42:3883-5.
44. Hijikata M, Hayashi S, Trinh NT, Ha LD, Ohara H, Shimizu YK, et al. Genotyping of hepatitis E virus from Vietnam. Intervirology 2002;45:101-4.
45. Corwin AL, Khiem HB, Clayson ET, Sac PK, Nhung VTT, Yen VT, et al. A waterborne outbreak of hepatitis E virus transmission in southwestern Vietnam. Am J Trop Med Hyg 1996;54:559-62.
46. Tran HTT, Ushijima H, Quang VX, Phuong N, Li TC, Hayashi S, et al. Prevalence of hepatitis virus types B through E and genotypic distribution of HBV and HCV in Ho Chi Minh City, Vietnam. Hepatol Res 2003;26:275-80.
47. Wibawa IDN, Suryadarma IGA, Mulyanto, Tsuda F, Matsumoto Y, Ninomiya M, et al. Identification of genotype 4 hepatitis E virus strains from a patient with acute hepatitis E and farm pigs in Bali, Indonesia. J Med Virol 2007;79:1138-46.
48. Wibawa IDN, Muljono DH, Mulyanto, Suryadarma IGA, Tsuda F, Takahashi M, et al. Prevalence of Antibodies to Hepatitis E Virus among Apparently Healthy Humans and Pigs in Bali, Indonesia: Identification of A Pig Infected with A Genotype 4 Hepatitis E Virus. J Med Virol 2004;73:38-44.
49. Surya IGP, Kornia K, Suwardewa TGA, Mulyanto, Tsuda F, Mishiro S. Serological markers of hepatitis B, C, and E viruses and human immunodeficiency virus type-1 infections in pregnant women in Bali, Indonesia. J Med Virol 2005;75:499-503.
50. Tan LTC, Tan J, Ang LW, Chan KP, Chiew KT, Cutter J, et al. Epidemiology of acute hepatitis E in Singapore. J Infect 2013;66:453-9.
51. Liu X, Saito M, Sayama Y, Suzuki E, Malbas FF, Galang HO, et al. Seroprevalence and molecular characteristics of hepatitis E virus in household-raised pig population in the Philippines. BMC Vet Res 2015;11(1).
52. Myint KSA, Duripunt P, Mammen MP, Sirisopana N, Rodkvamtook W, Gibbons R V. Hepatitis E Virus Infection in Thai Troops Deployed with U.N. Peacekeeping Forces. Mil Med 2007;172:1217-9.
53. Xin S, Xiao L. Clinical manifestations of hepatitis E. In: Advances in Experimental Medicine and Biology. Springer New York LLC; 2016.p.175-89.
54. Kamar N, Selves J, Mansuy J-M, Ouezzani L, Péron J-M, Guitard J, et al. Hepatitis E Virus and Chronic Hepatitis in Organ-Transplant Recipients. N Engl J Med 2008;358:811-7.
55. Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. Persistent Carriage of Hepatitis E Virus in Patients with HIV Infection. N Engl J Med 2009;361:1025-7.
56. Colson P, Kaba M, Moreau J, Brouqui P. Hepatitis E in an HIV-infected patient. J Clin Virol 2009;45:269-71.
57. Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology 2012;55:988-97.
58. Aggarwal R. Diagnosis of Hepatitis E. Nat Rev Gastroenterol Hepatol 2013;10:24-33.
59. Kmush BL, Labrique AB, Dalton HR, Ahmed ZB, Ticehurst JR, Heaney CD, et al. Two generations of “gold standards”: The impact of a decade in hepatitis e virus testing innovation on population seroprevalence. Am J Trop Med Hyg 2015;93:714-7.
60. Pas SD, Streefkerk RHRA, Pronk M, de Man RA, Beersma MF, Osterhaus ADME, et al. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients. J Clin Virol 2013;58:629-34.
61. Takahashi M, Kusakai S, Mizuo H, Suzuki K, Fujimura K, Masuko K, et al. Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) is highly specific for diagnosis of acute HEV infection. J Clin Microbiol 2005;43:49-56.
62. Favorov MO, Fields HA, Purdy MA, Yashina TL, Aleksandrov AG, Alter MJ, et al. Serologic identification of hepatitis E virus infections in epidemic and endemic settings. J Med Virol 1992;36:246-50.
63. Sultan Khuroo M, Kamili S, Yousuf Dar M, Moecklii R, Jameel S. Hepatitis E and long-term antibody status. Lancet 1993;341:1355.
64. Pisanic N, Rahman A, Saha SK, Labrique AB, Nelson KE, Granger DA, et al. Development of an oral fluid immunoassay to assess past and recent hepatitis E virus (HEV) infection. J Immunol Methods 2017;448:1-8.
65. Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, et al. Efficacy and safety of a recombinant hepatitis e vaccine in healthy adults: A large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010;376:895-902.
66. Zhang J, Zhang XF, Huang SJ, Wu T, Hu YM, Wang ZZ, et al. Long-term efficacy of a hepatitis E vaccine. N Engl J Med 2015;372:914-22.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following conditions:
Copyright Transfer
In submitting a manuscript, the authors acknowledge that the work will become the copyrighted property of Siriraj Medical Journal upon publication.
License
Articles are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). This license allows for the sharing of the work for non-commercial purposes with proper attribution to the authors and the journal. However, it does not permit modifications or the creation of derivative works.
Sharing and Access
Authors are encouraged to share their article on their personal or institutional websites and through other non-commercial platforms. Doing so can increase readership and citations.